Amoy Diagnostics Co., Ltd. Sustainability Profile
Amoy Diagnostics Co., Ltd., commonly referred to as AmoyDx, is a leading biotechnology company headquartered in China. Established in 2008, the company has made significant strides in the field of molecular diagnostics, focusing on oncology and infectious diseases. With a strong presence in Asia and expanding operations globally, AmoyDx is renowned for its innovative diagnostic solutions. The company offers a range of core products, including advanced PCR-based assays and next-generation sequencing (NGS) technologies, which are distinguished by their high sensitivity and specificity. AmoyDx has achieved notable recognition in the industry, positioning itself as a trusted partner for healthcare providers and researchers alike. With a commitment to enhancing patient outcomes, AmoyDx continues to drive advancements in precision medicine and diagnostics.
DitchCarbon Score
How does Amoy Diagnostics Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Amoy Diagnostics Co., Ltd.'s score of 22 is lower than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Amoy Diagnostics Co., Ltd.'s reported carbon emissions
Amoy Diagnostics Co., Ltd., headquartered in China, has made significant commitments towards reducing its carbon emissions, although specific emissions data is currently unavailable. As of October 2023, the company is committed to near-term reduction targets, reflecting its dedication to addressing climate change within the healthcare sector. While no absolute emissions figures are provided, Amoy Diagnostics is actively engaged in sustainability initiatives and has pledged to align its operations with industry standards. The company has not yet set a net-zero target but remains focused on reducing its carbon footprint through various strategies. The emissions data and climate commitments are sourced directly from Amoy Diagnostics Co., Ltd., indicating a proactive approach to environmental responsibility without reliance on cascaded data from parent or related organizations. As a participant in the healthcare providers and services sector, Amoy Diagnostics is positioned to contribute positively to climate action efforts.
How Carbon Intensive is Amoy Diagnostics Co., Ltd.'s Industry?
How Carbon Intensive is Amoy Diagnostics Co., Ltd.'s Location?
Amoy Diagnostics Co., Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Amoy Diagnostics Co., Ltd. has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
